Tesamorelin 10mg (GHRH Analog) Lab Grade Research Peptide — 99%+ Purity

Tesamorelin is a synthetic 44-amino-acid peptide analog of growth hormone-releasing hormone (GHRH) originally developed for clinical investigation of growth hormone secretion, body composition, and metabolic health. Tesamorelin is studied extensively for its ability to stimulate endogenous growth hormone (GH) secretion through pituitary somatotroph activation, making it valuable for preclinical research into GH physiology, aging, metabolism, and body composition regulation. This Tesamorelin 10mg lyophilized research peptide is a tool for investigating growth hormone signaling, metabolic adaptation, and age-related physiological changes in research models.

What Is Tesamorelin?

Tesamorelin (also known as Tesamorelin acetate, GRF(1-44)-NH2 analog) is a synthetic 44-amino-acid peptide that functions as an analog of endogenous growth hormone-releasing hormone (GHRH), the natural hypothalamic neuropeptide that stimulates growth hormone secretion from the anterior pituitary. Unlike recombinant growth hormone (rhGH), which directly replaces circulating GH, tesamorelin works upstream at the level of the hypothalamic-pituitary axis, stimulating the body's own GH-secreting cells (somatotrophs) to produce and release growth hormone. This makes tesamorelin valuable for studying endogenous GH dynamics, pituitary function, and metabolic effects of GH secretion independent of exogenous GH administration. Tesamorelin was developed and clinically investigated for its effects on body composition, metabolic markers, and age-related physiological changes.

Tesamorelin Mechanisms of Action

Tesamorelin operates through the hypothalamic-pituitary-GH axis to stimulate endogenous growth hormone secretion. The peptide binds to GHRH receptors (GHRH-R) on anterior pituitary somatotroph cells, activating intracellular signaling cascades (cAMP/PKA pathway) that stimulate synthesis and secretion of growth hormone. Elevated circulating GH subsequently acts on GH receptors distributed throughout the body to exert anabolic and metabolic effects: increased lipolysis (fat breakdown), enhanced protein synthesis, improved insulin sensitivity, increased lean body mass, and metabolic rate elevation. Unlike pharmacological GH secretagogues (e.g., ghrelin agonists like ipamorelin), tesamorelin specifically targets the physiological GHRH pathway, making it a more selective tool for investigating natural GH secretion mechanisms. Importantly, tesamorelin stimulates GH in a pulsatile, nutrient- and sleep-dependent manner that mirrors endogenous GH physiology, rather than producing artificial continuous elevation.

Tesamorelin Research Applications

Preclinical and translational research documents tesamorelin investigation for:

• Growth hormone secretion and pituitary function
• Body composition and lean mass regulation
• Lipolysis and fat metabolism
• Insulin sensitivity and glucose homeostasis
• Aging-related decline in GH secretion (somatopause)
• Metabolic syndrome and obesity models
• Energy expenditure and resting metabolic rate
• Protein synthesis and muscle anabolism
• Cardiovascular metabolic markers
• Lipodystrophy and fat redistribution
• GH receptor signaling and physiology
• Interaction with other hormonal axes (insulin, thyroid)
• Age-related physiological changes and frailty

Tesamorelin vs. Growth Hormone

Recombinant growth hormone (rhGH, somatropin) directly replaces circulating GH and produces continuous elevation independent of hypothalamic-pituitary control. In contrast, tesamorelin stimulates the body's own GH production via the natural pituitary-GH axis, maintaining physiological GH pulsatility (episodic secretion tied to sleep and nutrition) and negative feedback control. This distinction is scientifically valuable: tesamorelin research investigates endogenous GH physiology and how the hypothalamic-pituitary system responds to signaling challenges, whereas GH research examines effects of sustained elevated circulating GH. Additionally, tesamorelin avoids some of the feedback complications and tolerance concerns associated with chronic GH replacement, making it a tool for studying natural GH secretion mechanisms and age-related GH declines.

Tesamorelin and Aging (Somatopause)

Growth hormone secretion declines dramatically with age—a phenomenon called "somatopause." By age 80, average GH secretion is reduced by 50–80% compared to young adults. This GH decline contributes to aging phenotypes: loss of lean muscle mass, increased adiposity (especially visceral fat), reduced metabolic rate, impaired glucose control, and decreased bone density and strength. Tesamorelin research in aging models examines whether stimulating endogenous GH secretion can reverse or attenuate age-related physiological decline, improve body composition, restore metabolic function, and enhance physical performance and quality of life. This makes tesamorelin relevant to investigating biological aging mechanisms and potential interventions.

Tesamorelin Specifications

Compound	Tesamorelin (GHRH analog, 44-amino-acid peptide)
Quantity	10mg per vial (lyophilized)
Form	Lyophilized powder
Purity	≥99% (HPLC verified)
Sequence	44-amino-acid GHRH analog
Molecular Weight	Available on COA
Storage	-20°C (lyophilized); 2-8°C (reconstituted)
CAS Number	Available on COA
Appearance	White to off-white lyophilized powder
Packaging	Sealed sterile glass vial

Quality Verification

• HPLC purity verification (≥99%)
• Mass spectrometry sequence and identity confirmation
• Amino acid composition analysis
• Endotoxin and microbial contamination testing
• Certificate of Analysis (COA) included with every order

Reconstitution & Handling

Tesamorelin 10mg is reconstituted with bacteriostatic water for laboratory research. Add the diluent slowly down the inside wall of the vial to ensure complete dissolution without foaming. Once reconstituted, store the solution at 2-8°C and protect from light. Prepare aliquots to avoid repeated freeze-thaw cycles. Always follow institutional protocols for peptide handling, storage, and documentation in compliance with research regulations.

Frequently Asked Questions

What is tesamorelin and how does it work?

Tesamorelin is a 44-amino-acid GHRH analog that stimulates the pituitary to secrete endogenous growth hormone (GH). It binds to GHRH receptors on pituitary somatotroph cells, activating them to produce GH, which then exerts anabolic and metabolic effects throughout the body. Unlike exogenous GH, tesamorelin maintains physiological GH pulsatility.

How is tesamorelin different from growth hormone?

Tesamorelin stimulates the body's own GH secretion via the hypothalamic-pituitary axis, maintaining natural pulsatile GH patterns and feedback control. Exogenous growth hormone (rhGH) directly replaces GH and produces continuous elevation independent of pituitary control. Tesamorelin is a tool for studying endogenous GH physiology; GH is for studying effects of sustained GH elevation.

What is the purity of CoreVionRX tesamorelin?

CoreVionRX tesamorelin 10mg is ≥99% purity, verified by HPLC and confirmed by mass spectrometry. Sequence identity and amino acid composition are verified. Each batch includes a Certificate of Analysis documenting purity, molecular weight, and sterility testing.

How should tesamorelin be stored and reconstituted?

Store the lyophilized vial at -20°C for maximum stability. Reconstitute with bacteriostatic water by adding slowly down the vial wall. After reconstitution, store at 2-8°C, protect from light, and prepare small aliquots to avoid freeze-thaw cycles.Tesamorelin is supplied strictly for laboratory and research use only. Not for human or animal consumption.